Abstract
Patients with obstructive sleep apnea are at greater risk of cardiovascular morbidity and mortality. The prevalence of obstructive sleep apnea also seems to be higher in patients with cardiovascular conditions. Obstructive sleep apnea and coronary artery disease share some common risk factors while the pathophysiological interaction between them includes neural, humoral, mechanical and hemodynamic components. In this review we focus on the association between obstructive sleep apnea and coronary disease on the basis of their pathophysiological interaction, inflammatory mechanisms and to the effects of sleep apnea therapy on coronary disease outcomes.
Keywords: Obstructive sleep apnea, coronary heart disease, cardiovascular risk, systemic inflammation.
Current Respiratory Medicine Reviews
Title:Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further
Volume: 11 Issue: 4
Author(s): Andriana I. Papaioannou, Konstantinos Kostikas and Spyros Papiris
Affiliation:
Keywords: Obstructive sleep apnea, coronary heart disease, cardiovascular risk, systemic inflammation.
Abstract: Patients with obstructive sleep apnea are at greater risk of cardiovascular morbidity and mortality. The prevalence of obstructive sleep apnea also seems to be higher in patients with cardiovascular conditions. Obstructive sleep apnea and coronary artery disease share some common risk factors while the pathophysiological interaction between them includes neural, humoral, mechanical and hemodynamic components. In this review we focus on the association between obstructive sleep apnea and coronary disease on the basis of their pathophysiological interaction, inflammatory mechanisms and to the effects of sleep apnea therapy on coronary disease outcomes.
Export Options
About this article
Cite this article as:
Papaioannou I. Andriana, Kostikas Konstantinos and Papiris Spyros, Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further, Current Respiratory Medicine Reviews 2015; 11 (4) . https://dx.doi.org/10.2174/1573398X11666150915212917
DOI https://dx.doi.org/10.2174/1573398X11666150915212917 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders New Strategy on Antimicrobial-resistance: Inhibitors of DNA Replication Enzymes
Current Medicinal Chemistry Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Cardiac Cell Therapy and Bypass Surgery
Current Pharmaceutical Design Moving Troponin Testing into the 21st Century: Will Greater Sensitivity Be Met with Greater Sensibility?
Cardiovascular & Hematological Disorders-Drug Targets Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders MicroRNAs Patents: The Road From Bench to Bedsides for Cancer Treatment
Recent Patents on DNA & Gene Sequences Editorial [Hot Topic: New Drug Targets for the Treatment of Asthma (Guest Editor: D. Knight)]
Current Drug Targets Microarray Profiling Analysis Uncovers Common Molecular Mechanisms of Rubella Virus, Human Cytomegalovirus, and Herpes Simplex Virus Type 2 Infections in ECV304 Cells
Current Molecular Medicine Intravenous Thrombolysis with rt-PA in Acute Stroke Patients Aged ≥80 Years
Letters in Drug Design & Discovery Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Current Pharmaceutical Design Cardio-Renal-Anemia Syndrome: A Link Between Erythropoietin, Dimethylarginine and Homocysteine
Current Medicinal Chemistry Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
Current Drug Targets Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy
Vascular Disease Prevention (Discontinued) Limitations and Potential Clinical Application on Contrast Echocardiography
Current Cardiology Reviews Overexpression of a Modified Amaranth Protein in Escherichia coli with Minimal Media and Lactose as Inducer
Recent Patents on Biotechnology Detection of Ventricular Arrhythmias using HRV Analysis and Quadratic Features
Recent Advances in Electrical & Electronic Engineering Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysis
Cardiovascular & Hematological Disorders-Drug Targets Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
Current Pharmaceutical Design Lentinus edodes: A Macrofungus with Pharmacological Activities
Current Medicinal Chemistry